INFANRIX
STN: BL 103647
Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Tradename: INFANRIX
Manufacturer: GlaxoSmithKline Biologicals
Indications:
- INFANRIX is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).
Product Information
Supporting Documents
- October 27, 2023 Approval Letter - INFANRIX
- July 20, 2023 Approval Letter - INFANRIX
- November 23, 2022 Approval Letter - INFANRIX
- November 6, 2019 Approval Letter - INFANRIX
- Supporting Documents older than three years - INFANRIX